NCT06327880View on ClinicalTrials.gov

A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 13, 2024

Primary Completion Date

July 2, 2024

Study Completion Date

July 2, 2024

Conditions
Healthy
Interventions
DRUG

PF-07054894 or placebo

multiple oral doses of PF-07054894 for 14 days

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06327880 - A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin | Biotech Hunter | Biotech Hunter